LMG Life Sciences Americas 2024: research cycle open

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Americas 2024: research cycle open

Life Sciences website image 2024.png

The Americas research cycle has commenced. Do not miss this opportunity to nominate your work!

LMG Life Sciences is excited to announced the launch of the 2024 Americas research. We continue to recognize the top firms, lawyers, and legal work serving the Life Sciences industry from across the United States, Canada, and select jurisdictions within Latin America.

The deadline for submissions is 31 May 2024.

You can find detailed information about the rankings and awards by reviewing the methodology or reading the FAQs.

The full list of categories for the rankings and awards can be found on the LMG Life Sciences website.

Important Dates:

Submissions Open

Submissions Close

Shortlist Published

Gala Ceremony

Rankings Published

11 April 2024

31 May 2024

July 2024


September 2024

September 2024


All research submissions must be entered through our dedicated submissions platform. Submissions made in any other format or emailed to us will not be accepted.

For any questions about the awards and/or the rankings research, please contact Research Editor, John Harrison and Research Analyst, Jose Martinez.

For queries about business development and commercial opportunities, please contact George Reeves.

Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IPSTARS research.

more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article